Clinical Trial Update: Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase I/II clinical trial evaluating sss40 injection for moderate-to-severe pain from bone metastases in cancer patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Cancer Pain

Drugs mentioned

• sss40 injection (sss40)

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Cancer Pain | Phase 1, Phase 2 | Status: RECRUITING